Results 91 to 100 of about 6,302,624 (294)
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, 20 November - 12 December 1987.Curator: Lesley ...
200 Gertrude Street (Gallery)
core
200 Countries and 200 Years in 4 Minutes
Ein Fehler ist aufgetreten. Sieh dir dieses Video auf www.youtube.com an oder aktiviere JavaScript, falls es in deinem Browser deaktiviert sein sollte.
openaire +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Vic., 6-28 Sept. 1996.
200 Gertrude Street (Gallery)
core
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Peripheral visions : Andrew Arnaoutopoulos, Graeme Hare, Constanze Zikos
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Vic. 2-31 Oct.
200 Gertrude Street (Gallery)
core
Profiling cells with DELs: Small molecule fingerprinting of cell surfaces
DNA-encoded small molecule library technology has recently emerged as a new paradigm for identifying ligands against drug targets. To date, it has been used to identify ligands against targets that are soluble or overexpressed on cell surfaces.
Jason Deng +14 more
doaj +1 more source
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Vic. 7 - 29 Apr.
200 Gertrude Street (Gallery)
core

